What researchers published on Petefészekrák
43 189 papers, newest first.
Showing 60 of 43 189
ÁttekintésTumor-associated macrophages in ovarian, prostate, thyroid and pancreatic neuroendocrine tumors: molecular crosstalk and therapeutic perspectives.Molecular biology reports
Generation of mixed ovarian cancer and fibroblast spheroids by bioprinting.In vitro models
ÁttekintésAdvances in Biomarker Discovery for Early Ovarian Cancer Diagnosis.Cells
Diagnostic Performance of Contrast-Enhanced Computed Tomography in Predicting Lymph Node Metastasis in Epithelial Ovarian Cancer: The Added Value of Combining CT with CA-125.Diagnostics (Basel, Switzerland)
Infrared Treatment Alters the Chemical Profile and In Vitro Bioactivity of Jojoba Oil: Antimicrobial, Biofilm Formation Inhibition and Ovarian Cancer Cell Responses.International journal of molecular sciences
FABP4 is associated with ROS-dependent ferroptosis inhibition and platinum resistance in ovarian cancer.Tissue & cell
ÁttekintésImmune Resistance and Anti-Tumor Immunity in the Ovarian Tumor Microenvironment.Cells
PADI2 facilitates progression and cisplatin resistance of epithelial ovarian cancer via m6A methylation.iScience
Biologic and immunologic characteristics of ovarian cancers that are associated with p53 autoantibodies.Cancer
ÁttekintésPrognostic Value of the KELIM Score Versus Conventional CA-125 Kinetics in Ovarian Cancer: A Systematic Review and Meta-Analysis.Diagnostics (Basel, Switzerland)
Comparison of Sonidegib and Vismodegib Efficiency in Drug-Sensitive and Resistant Ovarian Cancer Cell Lines-2D and 3D Model Study.International journal of molecular sciences
ÁttekintésThe Role of D-3-Phosphoglycerate Dehydrogenase (PHGDH) in Chemoresistance in Ovarian Cancer: Molecular Insights and Therapeutic Potential.International journal of molecular sciences
Multicenter Evaluation of Decentralized Homologous Recombination Deficiency Testing for Enhanced Molecular Diagnosis of Ovarian Cancer.International journal of molecular sciences
A leakage-aware and interpretable machine learning framework for ovarian cancer prediction using the PLCO screening dataset.Frontiers in oncology
Hypoxia-Associated Glycolytic-Lipogenic Reprogramming and Impaired Antigen Presentation in SPP1+ Tumor-Associated Macrophages in Ovarian Cancer.International journal of molecular sciences
Correction: Gralewska-Zając et al. Liposomal Vitamin C as a Modulator of the Efficacy of Ceralasertib Therapy in Ovarian Cancer. Int. J. Mol. Sci. 2026, 27, 2630.International journal of molecular sciences
ÁttekintésFolate Receptor Alpha (FRα/FOLR1) in Cancer: Diagnostic, Prognostic or Predictive Biomarker? A Critical Review of Its Clinical Utility.International journal of molecular sciences
Comparison of Survival Outcomes with First-Line PARP Inhibitor Maintenance According to BRCA Mutation and Homologous Recombination Deficiency Status in Advanced Ovarian Cancer: A Single-Center Retrospective Cohort Study.Cancers
ÁttekintésExtracellular Vesicle-Associated Epithelial-Mesenchymal Plasticity (EMP) as a Driver of Metastatic Evolution and Therapeutic Resistance in Ovarian Cancer.Cancers
Platelet-Derived Extracellular Vesicles for the Diagnosis of Ovarian Cancer.Cancers
"Hearing the Ovarian Cancer Whisper": A Pipeline Program Introducing Medical Students to Gynecologic Oncology, Focusing on the Diagnosis and Management of Ovarian Cancer.Medical science educator
Minimally invasive surgery improves surgical and analgesic outcomes in overweight or obese patients with borderline ovarian tumors: A retrospective cohort study.Medicine
Compartment-Resolved Profiling Identifies Shared Stromal Programs and Clarifies Molecular Subtype Origins in Ovarian Cancer.Cancer research
ÁttekintésCellular senescence in ovarian cancer: context-dependent effects on tumor immunity and therapy response.Frontiers in immunology
Risk Factor Profiles May Differ Between Younger-Onset and Late-Onset Colorectal Cancer: An Exploratory Analysis of Individual and Cumulative Risk Factors Among the Prostate, Lung, Colorectal and Ovarian Cohort.Asia-Pacific journal of clinical oncology
Multi-omics-constrained kinetic models quantify pathway rewiring and predict metabolic vulnerabilities in BRCA1-deficient ovarian cancer.Cell systems
Clinical characteristics and treatment strategies of ovarian teratomas associated with anti-N-methyl-D-aspartate receptor encephalitis based on a case series.Frontiers in neurology
Tuberculous Salpingo-Oophoritis Mimicking Ovarian Malignancy: A Case Report of a Diagnostic Dilemma.Clinical case reports
MRPL47 as a mitochondrial biomarker for early detection and therapeutic response in ovarian cancer.Molecular therapy. Oncology
Surgical opportunities for primary prevention of high-grade serous ovarian cancer: a procedure-level analysis of opportunistic salpingectomy.Journal of ovarian research
Perillaldehyde (PAE) Regulates Ovarian Cancer by Modulating HSP70 and Regulating the PI3K/AKT Signaling Pathway.Archives of biochemistry and biophysics
Vizsgálati eredményPamiparib plus surufatinib with ctDNA monitoring in platinum-resistant ovarian cancer after PARP inhibitor progression: a phase Ib/II trial (POST-PARPi).BMC medicine
AIF promotes ovarian cancer progression by competitively binding TRAP1 to stabilize MtCK1 to drive phosphocreatine synthesis.Journal of translational medicine
Fertility-sparing surgery for early-stage epithelial ovarian cancer: evolving criteria for patient selection.Japanese journal of clinical oncology
Randomizált vizsgálatFuzuloparib in combination with apatinib versus fuzuloparib alone for recurrent ovarian cancer: a randomized, open-label, phase 2 trial.Journal of ovarian research
PD-L1 expression in epithelial ovarian cancer and survival: a retrospective cohort study.Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia
Racial and ethnic differences in ovarian cancer survival across SEER registry states.Gynecologic oncology
ÁttekintésThe hidden genome of high-grade serous ovarian carcinoma: repetitive DNA, extrachromosomal DNA, and complex structural variation.Frontiers in molecular biosciences
The p38α MAPK-MK2 axis drives chemotherapy-mediated nuclear actin remodeling to promote ovarian cancer progression.Proceedings of the National Academy of Sciences of the United States of America
Editorial: New horizons in the management of advanced epithelial ovarian cancer.Frontiers in medicine
Epigenetic Divergence Distinguishes Molecularly and Histologically Distinct Subtypes of Small Cell Carcinoma of the Ovary Hypercalcemic Type.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Cell-death-associated inflammatory remodeling of the SPP1/KRT5 axis in high-grade serous ovarian cancer: multi-omics, single-cell, and irradiation validation.Frontiers in cell and developmental biology
A peritoneal cancer index above 14 is associated with incomplete cytoreduction in cytoreductive surgery with HIPEC for high-grade serous ovarian cancer.European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Deep learning radiomics nomogram based on enhanced CT for differentiating epithelial ovarian borderline tumors and early-stage epithelial ovarian cancers.BMC cancer
Causal effects of genetically predicted CCL25 signaling on ovarian cancer risk: A 2-sample Mendelian randomization study.Medicine
EsetismertetésManagement of an incidentally discovered pancreatic neoplasm mimicking an ovarian neoplasm during pregnancy: A case report.Medicine
MetaanalízisPoly (ADP-ribose) polymerase inhibitors (PARPi) for treating advanced epithelial ovarian cancer.The Cochrane database of systematic reviews
Hypermethylation in CpG-rich cfDNA fragments enables accurate detection of circulating tumor DNA in BRCA1- and BRCA2-associated breast and ovarian cancer.NPJ breast cancer
Selective miRNA network modulation by quinolone derivative CF5 is associated with potent anti-ovarian cancer activity.Bioscience reports
ÁttekintésBEHOLD phase 3 clinical development program of mocertatug rezetecan in ovarian and endometrial cancer.Gynecologic oncology
[Oncogenetics consultation].Annales de chirurgie plastique et esthetique
Considerations on external validation, potential data leakage, and model selection in a PET/CT-based radiomics model predicting residual disease in ovarian cancer.Journal of ovarian research
Risovalisib for PIK3CA-mutated recurrent or persistent ovarian clear cell carcinoma: a single-arm, multicentre, phase 2 trial.The Lancet. Oncology
Identification and Biological Evaluation of Fisetin as a Novel DYRK1B Inhibitor in Ovarian Cancer with Apoptotic and Ferroptotic Effects.Drug design, development and therapy
Prospective Analysis of Breastfeeding History and Ovarian Cancer Risk: Results From the Ovarian Cancer Cohort Consortium.International journal of cancer
EsetismertetésBreast metastasis from BRCA1-mutated ovarian cancer: response to parp inhibition and a potential lymphatic route.BMC women's health
ÁttekintésAdvances in the application of fluorescent probes for ovarian cancer.Journal of ovarian research
Blood-based RNA biomarker for the early detection of ovarian cancer.Nature medicine
Correction: Carboxylesterase 1 is a core metabolic vulnerability of platinum-resistant high-grade serous ovarian carcinoma.Journal of experimental & clinical cancer research : CR
A novel candidate biomarker for detecting premalignant and early ovarian cancer.Nature medicine